Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Increase patent revenue for oral and non oral drug delivery products

Abstract:
Examining the latest developments in nanomedicine and enhancing in vivo circulation time, extending dissolution kinetics, and improving delivery with drug-porous nanocarriers, lipid-based compounds and biologics.

Increase patent revenue for oral and non oral drug delivery products

UK | Posted on March 4th, 2012

With less than a month to go join SMi at their 9th annual Controlled Release conference that will once again lead the way in examining the latest developments in nanomedicine and featuring fresh presentations from companies including GlaxoSmithKline, Lundbeck, Merck Serono and Genzyme.

Controlled Release will allow delegates to meet and network with key decision makers from the top pharmaceutical companies, as well as discuss & debate current issues such as challenges in drug formulation for oral delivery - where are we and what are the prospects for the future, challenges and opportunities for delivering biologics to the CNS and solutions for dissolution testing of non-oral formulations.

Network with key presenters within the pharmaceutical industry that includes:

• Peter Timmins, Executive Director, Drug Products, Science and Technology, Bristol-Myers Squibb
• Mark Wilson, Director, Collaboration Management, GlaxoSmithkline
• Simon Holland, Director, Process Understanding & Control, GlaxoSmithKline
• Bernd Riebesehl, Principal Fellow, Parenteral Dosage Forms, Pharmaceutical and Analytical Development, Novartis
• Mostafa Nakach, Head of the Pharmaceutical Engineering Group, Sanofi-Aventis
• Michael Keller, Senior Fellow, siRNA Project Leader, Technical Research and Development (TRD), Novartis
• Jonathan Brown, Senior Research Investigator, Bristol-Myers Squibb
• Tomas Landh, Director, Novo Nordisk
• Jan L. Powell, Director, Physiology, Shire HGT
• Lars Bauer, Senior Medical Director, Therapeutic Area CNS, UCB
• Karin Liltorp, Director, Preformulation, Lundbeck

####

For more information, please click here

Contacts:
Fateja Begum
Tel: +44 (0) 207 827 6184


Kellee Halliburton

Copyright © SMi Group

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

New organic molecule shatters phosphorescence efficiency records and paves way for rare metal-free applications July 5th, 2024

Single atoms show their true color July 5th, 2024

New method cracked for high-capacity, secure quantum communication July 5th, 2024

Searching for dark matter with the coldest quantum detectors in the world July 5th, 2024

Nanomedicine

The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024

Virginia Tech physicists propose path to faster, more flexible robots: Virginia Tech physicists revealed a microscopic phenomenon that could greatly improve the performance of soft devices, such as agile flexible robots or microscopic capsules for drug delivery May 17th, 2024

Diamond glitter: A play of colors with artificial DNA crystals May 17th, 2024

Advances in priming B cell immunity against HIV pave the way to future HIV vaccines, shows quartet of new studies May 17th, 2024

Announcements

New organic molecule shatters phosphorescence efficiency records and paves way for rare metal-free applications July 5th, 2024

Single atoms show their true color July 5th, 2024

New method cracked for high-capacity, secure quantum communication July 5th, 2024

Searching for dark matter with the coldest quantum detectors in the world July 5th, 2024

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters

Single atoms show their true color July 5th, 2024

New method cracked for high-capacity, secure quantum communication July 5th, 2024

Searching for dark matter with the coldest quantum detectors in the world July 5th, 2024

Atomic force microscopy in 3D July 5th, 2024

Patents/IP/Tech Transfer/Licensing

Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance May 13th, 2022

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

Events/Classes

A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed July 5th, 2024

Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023

CEA & Partners Present ‘Powerful Step Towards Industrialization’ Of Linear Si Quantum Dot Arrays Using FDSOI Material at VLSI Symposium: Invited paper reports 3-step characterization chain and resulting methodologies and metrics that accelerate learning, provide data on device pe June 17th, 2022

June Conference in Grenoble, France, to Explore Pathways to 6G Applications, Including ‘Internet of Senses’, Sustainability, Extended Reality & Digital Twin of Physical World: Organized by CEA-Leti, the Joint EuCNC and 6G Summit Sees Telecom Sector as an ‘Enabler for a Sustainabl June 1st, 2022

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project